We think that the relatively muted gains in most equity markets in recent weeks reflects how positive news about potential COVID-19 vaccines has been partly offset by the renewed surge of infections in many advanced economies. If this resurgence peters out and there is more good news about vaccines, we think stock markets could make further headway.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services